adenosine monophosphate has been researched along with Genetic Diseases, X-Chromosome Linked in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almario-Hernandez, AF; Doerholt, K; Drysdale, SB; Gilmour, C; Heath, PT; Pereira, NMD | 1 |
| Betschel, SD; Iaboni, A; Wong, N | 1 |
| Alagna, L; Bandera, A; Carrabba, M; Fabio, G; Fortina, V; Gori, A; Hu, C; Muscatello, A; Palomba, E; Saltini, P; Zuglian, G | 1 |
3 other study(ies) available for adenosine monophosphate and Genetic Diseases, X-Chromosome Linked
| Article | Year |
|---|---|
SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia.
Topics: Adenosine Monophosphate; Adolescent; Agammaglobulinemia; Alanine; Antibodies, Viral; Antiviral Agents; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Drug Treatment; Fever; Genetic Diseases, X-Linked; Humans; Inflammation; Male; Pneumonia, Viral; SARS-CoV-2 | 2021 |
A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma.
Topics: Adenosine Monophosphate; Adult; Agammaglobulinemia; Alanine; COVID-19; COVID-19 Serotherapy; Genetic Diseases, X-Linked; Humans; Immunization, Passive; Male | 2021 |
Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia.
Topics: Adenosine Monophosphate; Adult; Agammaglobulinemia; Alanine; Antibodies, Neutralizing; Antibodies, Viral; COVID-19 Drug Treatment; Genetic Diseases, X-Linked; Humans; Recurrence; SARS-CoV-2 | 2021 |